DNPUF Overview
Upcoming Projects (DNPUF)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DNPUF)
-
A Second Look: Discussing the updates on menin inhibitors that were released at ASH 2024.
Tickers: SNDX, KURA, JNJ, DNPUF
Executed On: Jan 27, 2025 at 03:00 PM EST -
Discussing the updates on menin inhibitors that were released at ASH 2024.
Tickers: SNDX, KURA, JNJ, DNPUF
Executed On: Jan 22, 2025 at 05:30 PM EST -
Third View: Discussing Sumitomo Pharma's FDA approval for GEMTESA (vibegron) for men with overactive bladder symptoms receiving pharmacological therapy for benign prostatic hyperplasia.
Ticker: DNPUF
Executed On: Jan 15, 2025 at 09:00 AM EST -
Second View: Discussing Sumitomo Pharma's FDA approval for GEMTESA (vibegron) for men with overactive bladder symptoms receiving pharmacological therapy for benign prostatic hyperplasia.
Ticker: DNPUF
Executed On: Jan 09, 2025 at 03:30 PM EST -
Discussing Sumitomo Pharma's FDA approval for GEMTESA (vibegron) for men with overactive bladder symptoms receiving pharmacological therapy for benign prostatic hyperplasia.
Ticker: DNPUF
Executed On: Jan 09, 2025 at 02:00 PM EST
Upcoming & Overdue Catalysts (DNPUF)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (DNPUF)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
